ライフサイエンスコーパス: SPECT

1 SPECT HMR was quantified using a new method that incorpo

2 SPECT images were reconstructed with 120 or 30 projectio

3 SPECT imaging revealed that (111)In-PEG-HVGGSSV specific

4 SPECT is most commonly used for clinical myocardial perf

5 SPECT MBF has been shown to be accurate when compared wi

6 SPECT MBF was measured in 30 patients and repeated at a

7 SPECT myocardial perfusion imaging has attained widespre

8 SPECT using new detectors allows the quantification of m

9 SPECT/CT images of (177)Lu-DOTA-PP-F11N in a metastatic

10 SPECT/CT images were obtained after 24 h.

11 SPECT/CT imaging and reconstruction deficiencies might d

12 SPECT/CT imaging in mice revealed that ATRAM accumulates

13 SPECT/CT imaging in patients with advanced breast cancer

14 SPECT/CT may be advantageous in patients planned for rig

15 SPECT/CT may be advantageous in patients planned for rig

16 SPECT/CT of the central skeleton covering the skull to t

17 SPECT/CT revealed a 4-fold higher median tumor uptake fo

18 (99m)Tc-PHC-102 SPECT/CT allowed the identification of 4 previously unkn

19 ivity data and new patients with only 1 or 2 SPECT/CT scans demonstrate less bias on average and sign

20 and heart to contralateral ratio 1.3 to 1.9, SPECT was needed to make a diagnosis.

21 nexpected potential of (99m)Tc-PSMA-I&S as a SPECT imaging agent.

22 , in particular the positional guidance of a SPECT/CT-based 3-dimensional imaging road map, in this p

23 , in particular the positional guidance of a SPECT/CT-based 3D imaging roadmap, in this process we st

24 was every fourth projection of 120 acquired SPECT projections, that is, 30 projections.

25 for the determination of absolute activity, SPECT phantom imaging studies and pre-clinical trials.

26 Additional SPECT/CT images were obtained after the whole-body image

27 m-diethylenetriaminepentaacetic acid aerosol SPECT ventilation imaging (hereafter, V-SPECT) in partic

28 m-diethylenetriaminepentaacetic acid aerosol SPECT ventilation imaging.

29 Twenty years ago, SPECT/CT became commercially available, combining the st

30 technetium 99m macroaggregated human albumin SPECT/CT was associated with better overall survival and

31 Although SPECT specificity improved in smaller compared with larg

32 Three users analyzed SPECT/CT images for in vivo urinary bladder radiotracer

33 Biodistribution and SPECT imaging were done on male nonobese diabetic/severe

34 Tissue biodistribution and SPECT/CT imaging of (203)Pb-L1-(203)Pb-L5 were performed

35 y CTA (0.83 and 0.81; p < 0.01 for both) and SPECT (0.70 and 0.75; p < 0.01 for both), on a per-vesse

36 d with different activity concentrations and SPECT/CT imaging was performed.

37 with different activity concentrations, and SPECT/CT imaging was performed.

38 ing was acquired at 1, 2, 3, 6, and 24 h and SPECT/CT at 6 h after tracer injection.

39 ET, the detection rate of planar imaging and SPECT was lower for lesions smaller than 2 cm than lesio

40 T/CT than for (123)I-MIBG planar imaging and SPECT/CT in 6 of 10 patients.

41 l image registration of baseline imaging and SPECT/CT, (90)Y distribution was quantified on SPECT as

42 ell as paired (123)I-MIBG planar imaging and SPECT/CT.

43 or to that of (123)I-MIBG planar imaging and SPECT/CT.

44 g was performed using lymphoscintigraphy and SPECT/CT.

45 imodal imaging, including hybrid PET/MRI and SPECT/CT.

46 therapy, combined with quantitative PET and SPECT imaging for dosimetry, have opened up exciting opp

47 ptic dopaminergic brain imaging with PET and SPECT is clinically widely used for patients with suspec

48 ing agent, comparing it with leading PET and SPECT lipophilic cationic tracers before further assessi

49 The specificities of PET and SPECT were similar in larger LVs (76% vs. 83%, P = 0.11)

50 PSMA) tracer that can be used for planar and SPECT/CT gamma-imaging and radioguided surgery.

51 ) and to estimate the accuracy of SC, PS and SPECT/CT in predicting post-operative pulmonary function

52 ements differed significantly between PS and SPECT/CT in right lung lobes, with a mean difference of

53 ements differed significantly between PS and SPECT/CT in right lung lobes, with a mean difference of

54 ll as (99m)Tc-macroaggregated albumin PS and SPECT/CT quantification.

55 -MAA lung perfusion scintigraphy with PS and SPECT/CT quantification.

56 uptake of the lung lobes estimated by PS and SPECT/CT was compared.

57 uptake of the lung lobes estimated by PS and SPECT/CT were compared.

58 meters differed significantly between PS and SPECT/CT, no significant differences were found between

59 meters differed significantly between PS and SPECT/CT, no significant differences were found between

60 e FEV1 and DLCO were derived from SC, PS and SPECT/CT.

61 and to estimate the accuracy of SC, PS, and SPECT/CT in predicting postoperative pulmonary function

62 FEV1 and DLCO were derived from SC, PS, and SPECT/CT.

63 was applied for diagnostic scintigraphy and SPECT of patients with metastasized ovarian and pancreat

64 11)In-pentetreotide planar scintigraphy, and SPECT/CT within 1 wk.

65 The quality of the SIPs and SPECT images was quantitatively evaluated with root-mean

66 On in vivo small-animal SPECT/CT and ex vivo planar images, the MMP signal was s

67 : Here we have used noninvasive small-animal SPECT/CT imaging and ex vivo biodistribution to understa

68 Small-animal SPECT/CT-based MMP-targeted imaging of the lungs is feas

69 owed for high image contrast in small-animal SPECT/CT.

70 for biodistribution studies and small-animal SPECT/CT.

71 a (often with stress myocardial perfusion at SPECT, PET, and cardiac MRI) and visualization of the co

72 general-purpose cadmium-zinc-telluride-based SPECT/CT system.

73 ugh this leads to a better agreement between SPECT/CT-based and nominal values, considerable discrepa

74 e, PETPVC largely improves the match between SPECT/CT-based and nominal dose distributions.

75 astatic PCa via sequential planar whole-body SPECT imaging at 1, 3, 5, and 21 h after injection.

76 Then, the data of 28 whole-body SPECT/CT scans of 7 patients who underwent (177)Lu prost

77 More recently, the design of whole-body SPECT/CT systems has taken another major leap with the i

78 or CT was obtained before and Bremsstrahlung SPECT within 2 h after TARE.

79 (90)Y bremsstrahlung SPECT images were transformed into dose maps assuming th

80 We characterized (111)In-DOTA-5D3 by SPECT/CT imaging, tissue biodistribution studies, and do

81 tests and blood-brain barrier disruption by SPECT/CT imaging after injection of (99m)Tc-DTPA, an ima

82 e radiolabeled with (177)Lu and evaluated by SPECT/CT imaging and biodistribution studies in LNCaP tu

83 detect by conventional CT or MRI and even by SPECT with the currently available radiotracers (e.g., m

84 Planar scintigraphy followed by SPECT imaging was performed after 2, 4, 6, and 24 h.

85 uticals was measured 24 h after injection by SPECT/CT.

86 he preoperative imaging road map provided by SPECT/CT enhanced the detection of prostate SNs in more

87 The preoperative imaging roadmap provided by SPECT/CT enhanced the detection of prostate SNs in more

88 o imaging of MMP activity in tumor tissue by SPECT.

89 Biodistribution was performed in vivo by SPECT-CT imaging and post-mortem.

90 Biodistribution was performed in vivo by SPECT/CT imaging and after death.

91 riers (ie, premotor), in whom [(123)I]FP-CIT SPECT confirmed the absence of striatal dopaminergic def

92 Three (123)I-FP-CIT SPECT quantitative assessment methods-MIMneuro, DaTQUANT

93 All 3 (123)I-FP-CIT SPECT quantitative methods had an area under the receive

94 Conclusion: All 3 (123)I-FP-CIT SPECT quantitative methods showed excellent discriminati

95 eta-(4-iodophenyl)nortropane ((123)I-FP-CIT) SPECT quantitative methods in patients with neurodegener

96 Methods: (123)I-FP-CIT-SPECT and neuropathologic findings among patients with n

97 nd [(123)I]FP-CIT single-photon emission CT (SPECT) to assess striatal dopamine transporter binding a

98 CT, MRI, PET, and single photon emission CT [SPECT]) to the mean level of high-income countries, both

99 stic performance than standard coronary CTA, SPECT, and PET for vessel-specific ischemia, provided co

100 prognostic value of MPI performed with a CZT SPECT camera in a large cohort of patients suspected of

101 r findings show that MPI acquired with a CZT SPECT camera provides excellent prognostic information,

102 nclusion: Myocardial perfusion images from D.SPECT are enhanced for patients positioned in a forward-

103 s from vertical, had an additional resting D.SPECT recording in the supine position (n = 40) or in th

104 erfusion imaging with the high-sensitivity D.SPECT cadmium-zinc-telluride camera in a forward-leaning

105 ion, with the chest leaning forward on the D.SPECT camera-head at 35 degrees from vertical, had an ad

106 previous planar HMR threshold and determined SPECT LLN HMR for SPECT.

107 entrations, as determined from the different SPECT images, were compared.

108 gents targeting PSMA have been developed for SPECT and PET platforms.

109 R threshold and determined SPECT LLN HMR for SPECT.

110 was lower than that previously reported for SPECT.

111 lications, including emerging techniques for SPECT MPI flow estimation.

112 with strictly normal contractility at gated SPECT and no defect reversibility from stress images.

113 CT scan at baseline, a posttreatment (166)Ho SPECT/CT scan, and another (18)F-FDG PET/CT scan at the

114 tivity distribution on posttreatment (166)Ho SPECT/CT.

115 urpose solid-state camera systems and hybrid SPECT/CT systems have also been developed that may have

116 CT technology have been introduced in hybrid SPECT/CT systems, replacing low-end x-ray tubes with hig

117 nts who underwent (18)F-FDG PET/CT or (131)I SPECT/CT for standard oncologic indications at our insti

118 ) was 23%, 38%, and 72% with planar imaging, SPECT, and SSTR PET, respectively.

119 targeting performance of (99m)Tc-PHC-102 in SPECT in patients with renal cell carcinoma while also a

120 tivity concentrations in vertebral bodies in SPECT images at 24 h after injection of (177)Lu-DOTATATE

121 Recent developments in SPECT hardware include solid-state digital systems with

122 The COV for the difference in SPECT MBF measurements obtained on separate days is 28%

123 There has been an evolutionary leap in SPECT imaging with the advent of camera systems that use

124 ecular and hybrid imaging methods, including SPECT/CT, PET/CT, and whole-body MRI.

125 lar and hybrid imaging techniques, including SPECT/CT, PET/CT, and whole-body MRI with diffusion-weig

126 Innovative SPECT radionuclide pairs have now become available for r

127 123I-ioflupane SPECT, MRI and neuropsychological testing were performed

128 ersus 4% HC had an abnormal (123)I-ioflupane SPECT scan (p=0.04).

129 s of PD/DLB and of abnormal (123)I-ioflupane SPECTs.

130 accuracy and image quality of multi-isotope SPECT is affected by various hardware-related perturbati

131 From a Jaszczak SPECT phantom, the recovery and signal-to-noise ratio (S

132 for L4-SPECT, -0.63 for V-SPECT, -0.63 for L-SPECT, and -0.57 for T-SPECT.

133 ation in the L4 vertebra, whereas V-SPECT, L-SPECT, and T-SPECT used the median activity concentratio

134 sing the planar method, L4-SPECT, V-SPECT, L-SPECT, and T-SPECT, the estimated median bone marrow abs

135 re -0.49 for the planar method, -0.61 for L4-SPECT, -0.63 for V-SPECT, -0.63 for L-SPECT, and -0.57 f

136 Results: Using the planar method, L4-SPECT, V-SPECT, L-SPECT, and T-SPECT, the estimated medi

137 of (177)Lu-DOTATATE in 4 hybrid methods: L4-SPECT used the activity concentration in the L4 vertebra

138 T and 1- or 2-day rest-stress Tc-99m-labeled SPECT and ICA.

139 he diagnostic performance of (99m)Tc-labeled SPECT MPI compared with (18)F-flurpiridaz PET MPI accord

140 s of this study were to decrease the (177)Lu-SPECT acquisition time by reducing the number of project

141 Visual agreement among CT, (99m)Tc-MAA SPECT/CT, and yttrium 90 ((90)Y) SPECT/CT or PET/CT was

142 (99m)Tc) macroaggregated human albumin (MAA) SPECT/CT.

143 sorbed doses of 7.8/1.6 Gy (cortex/medulla), SPECT/CT-based voxel-level dosimetry resulted in mean ab

144 ac MRI (CMR), (123)I-metaiodobenzylguanidine SPECT, and high-resolution bipolar voltage mapping to as

145 Methods: SPECT/CT imaging was performed after intraprostatic trac

146 Methods: SPECT/CT imaging was performed after intraprostatic trac

147 planar imaging (P < 0.0001) and (123)I-MIBG SPECT/CT (P < 0.0001).

148 nostic procedures such as MRI or (123)I-MIBG SPECT/CT.

149 At 4 h after PRLT, head-and-neck SPECT/CT was performed, and at both 4 and 24 h after PRL

150 opments have fueled efforts to develop novel SPECT radiopharmaceuticals, creating new chelators and p

151 or less and relative diagnostic accuracy of SPECT, PET, and CCTA in detecting hemodynamically signif

152 Combined analysis of SPECT myocardial perfusion imaging (MPI) performed with

153 addition, expanding clinical applications of SPECT/CT in other areas such as orthopedics offer exciti

154 a standardized and traceable calibration of SPECT/CT systems.

155 initially included attenuation correction of SPECT reconstructions, ultimately evolving to correction

156 In smaller LVs, there was a degradation of SPECT sensitivity that was highly significant (P < 0.001

157 The additional time and effort of SPECT/CT quantification may not have an added value in p

158 s to quantify (99m)Tc-DPD uptake by means of SPECT/CT before (223)Ra and compare the results with the

159 The number of SPECT investigations was 352 for training, 37 for valida

160 The performance of SPECT myocardial perfusion imaging (MPI) may deteriorate

161 of our study is to measure the precision of SPECT MBF measurements using (99m)Tc-tetrofosmin and a s

162 butions, thus questioning the reliability of SPECT-based voxel-level dosimetry.

163 Results of SPECT were identical at 1 and 3 hours.

164 th techniques: the diagnostic sensitivity of SPECT and the anatomic detail of CT.

165 tment dosimetry will likely drive the use of SPECT/CT in the near future.

166 On SPECT, (166)Ho could be quantified with high accuracy an

167 I&S was assessed in 10 patients with PCa on SPECT/CT images at 6 h.

168 cinoma also showed interstitial pneumonia on SPECT/CT.

169 ECT/CT, (90)Y distribution was quantified on SPECT as tumor-to-normal-liver ratio (TNR).

170 V% significantly correlated with high TNR on SPECT, demonstrating greater (90)Y uptake in the tumor r

171 sence of diffuse myocardial tracer uptake on SPECT.

172 The optimal SPECT scanning time for (177)Lu-DOTATATE was approximate

173 planar imaging (0.75 +/- 1.37; P < 0.001) or SPECT (1.23 +/- 1.57; P < 0.001).

174 gher for SSTR PET than for planar imaging or SPECT (0.79 vs. 0.67 and 0.50, respectively).

175 PET or SPECT studies comparing patients with atypical parkinson

176 s "dopamine" OR "dopaminergic" AND "PET" OR "SPECT" OR "SPET" and keywords related to PD, MSA, PSP, a

177 le to the prone position proposed with other SPECT cameras.

178 uding resection of SNs related to the ovary, SPECT/CT was performed within 24 h.

179 On positive uptake on octreotide-based PET/SPECT imaging, treatment is usually administered as a st

180 e isotopes using a multiplexed multi-pinhole SPECT system, assesses the extent of different error sou

181 lignant lesions can be identified on planar, SPECT, and PET scans.

182 metaiodobenzylguanidine (MIBG) scanning plus SPECT/CT.

183 Multiple-time-point SPECT/CT imaging for dosimetry is burdensome for patient

184 always associated with negative and positive SPECT, respectively.

185 light-chain cardiac amyloidosis had positive SPECT.

186 Post SPECT biodistribution data further validated tumor-speci

187 urgery with their detection on postoperative SPECT/CT.

188 te with (90)Y distribution on postprocedural SPECT and predict tumor response to transarterial radioe

189 predict (90)Y distribution on postprocedural SPECT in HCC and non-HCC.

190 ce-intensive, requiring multiple posttherapy SPECT acquisitions.

191 Preoperative SPECT/CT showed a high (99m)Tc-PSMA-I&S uptake in all su

192 Results: Preoperative SPECT/CT revealed no differences in the SN identificatio

193 Furthermore, at 4 h after PRLT, SPECT/CT showed no significant difference in counts or v

194 Conclusion: (99m)Tc-PHC-102 is a promising SPECT tracer for the imaging of patients with ccRCC.

195 ve lung function values according to SC, PS, SPECT/CT and the actual post-operative FEV1 and DLCO.

196 ve lung function values according to SC, PS, SPECT/CT, and the actual postoperative FEV1 and DLCO.

197 patients who underwent (99m)Tc-pyrophosphate SPECT/CT using a novel general-purpose cadmium-zinc-tell

198 Quantitative SPECT/CT imaging forms the basis for internal dosimetry

199 structions can provide absolute quantitative SPECT images with high image quality (subcentimeter reso

200 Conclusion: Quantitative SPECT/CT of bone scans performed at baseline is prognost

201 Improvements in quantitative SPECT/CT have aroused growing interest in voxel-based do

202 Due to improvements in quantitative SPECT/CT, voxel-based dosimetry for radionuclide therapi

203 : Our study showed that (177)Lu quantitative SPECT/CT imaging leads to voxel-based dose distributions

204 n: Our study shows that (177)Lu quantitative SPECT/CT imaging leads to voxel-based dose distributions

205 ter therapy, patients underwent quantitative SPECT/CT at 4, 24, and 96 h.

206 stributions were estimated with quantitative SPECT/CT reconstructions using a quantitative Monte Carl

207 ic Stroke of Undetermined Source) and the RE-SPECT ESUS (Dabigatran Etexilate for Secondary Stroke Pr

208 vers image quality and could allow a reduced SPECT acquisition time in clinical dosimetry protocols.

209 y (in the cortex and medulla, respectively), SPECT/CT-based voxel-level dosimetry resulted in mean ab

210 Results: SPECT performance decreased significantly from an area u

211 Results: SPECT/CT imaging blurs the 2 discrete suborgan absorbed

212 Results: SPECT/CT imaging blurs the two discrete sub-organ absorb

213 (99m)Tc-PSMA I&S SPECT/CT showed high TBR in PCa patients.

214 al organs and tumors were analyzed by serial SPECT/CT scans at 3 time points (30 min, 2 h, and 6 h) a

215 ing parathyroid gland or glands at sestamibi SPECT/CT and 4D CT were compared, per modality and in co

216 showed higher sensitivity than did sestamibi SPECT/CT (sensitivity, 79.3% [414 of 522] vs 58.0% [303

217 ent a combined imaging protocol of sestamibi SPECT/CT and 4D CT (noncontrast, contrast agent-enhanced

218 Both modalities outperformed sestamibi SPECT/CT (AUC, 0.78; 95% CI: 0.76, 0.81; P < .001).

219 ing methods, consisting of (99m)Tc-sestamibi SPECT/CT, (99m)Tc-sestamibi/pertechnetate subtraction im

220 4D CT had higher sensitivity than sestamibi SPECT/CT in patients with single-gland disease (sensitiv

221 found in both combined 4D CT with sestamibi SPECT/CT and 4D CT alone (area under the curve [AUC], 0.

222 erative localization compared with sestamibi SPECT/CT in patients with single and multigland disease.

223 tamibi (hereafter, referred to as sestamibi) SPECT/CT in preoperative localization in patients with p

224 Since SPECT is a lower-cost and more widely available alternat

225 sequential gamma-planar imaging and 1 single SPECT/CT) in healthy volunteers.

226 dosimetry, particularly using only a single SPECT scan, is on the rise.

227 Solid-state SPECT camera systems have facilitated dramatic reduction

228 view summarizes state-of-the-art solid-state SPECT MPI technology and clinical applications, includin

229 estamibi MPI with new-generation solid-state SPECT scanners in 4 different centers.

230 ower-energy (177)Lu energy peak, solid-state SPECT/CT imaging provided an accuracy to within approxim

231 cular Imaging, PET/CT, Radionuclide Studies, SPECT/CT (C) RSNA, 2020.

232 In this study, SPECT measurements of MBF made using (99m)Tc-tetrofosmin

233 L4 vertebra, whereas V-SPECT, L-SPECT, and T-SPECT used the median activity concentration in all visi

234 ar method, L4-SPECT, V-SPECT, L-SPECT, and T-SPECT, the estimated median bone marrow absorbed doses w

235 V-SPECT, -0.63 for L-SPECT, and -0.57 for T-SPECT.

236 imaging using a novel cadmium-zinc-telluride SPECT/CT scanner, SUV(max), SUV(mean), CAA, and %ID meas

237 a digital solid-state cadmium-zinc-telluride SPECT/CT system with in vitro sampling.

238 nt 256-slice coronary CTA, 99mTc-tetrofosmin SPECT, [(15)O]H(2)O PET, and routine 3-vessel invasive F

239 6.3%), significantly (p < 0.001) higher than SPECT (53.7% [95% CI: 48.5% to 58.8%]), while specificit

240 ET had significantly higher sensitivity than SPECT in both smaller LVs (67% vs. 43%, P < 0.001) and l

241 as not seen macroscopically, indicating that SPECT/CT imaging might be more sensitive than the macros

242 The SPECT/CT and basic fuchsin staining revealed significant

243 erienced observer qualitatively assessed the SPECT image quality of the test set.

244 PETPVC for partial-volume correction of the SPECT reconstructions.

245 Following unblinding of the SPECT/CT images, the number of missed SN's were recorded

246 After unmasking of the SPECT/CT images, the number of missed SNs was recorded a

247 er LVs, PET had a higher AUC (0.77) than the SPECT AUC (0.67) (P < 0.0001), a phenomenon driven by fe

248 Although it is true that the SPECT/CT ecosystem has seen several challenges during it

249 Therefore, we investigated whether the SPECT imaging agent (111)In-anti-gammaH2AX-TAT allows vi

250 Therefore, we investigated whether the SPECT imaging agent, (111)In-anti-gammaH2AX-TAT, allows

251 ce-intensive requiring multiple post-therapy SPECT acquisitions.

252 Therefore, SPECT/CT reconstructions should be adapted to ensure an

253 Therefore, SPECT/CT reconstructions should be adapted to ensure an

254 SMA(+) tumor lesions were visualized through SPECT/CT as early as 0.5 h after injection.

255 as to compare quantitative analysis of PS to SPECT/CT and to estimate the accuracy of SC, PS, and SPE

256 Flurpiridaz PET was superior to SPECT for defect size (p < 0.001), image quality (p < 0.

257 s not affected by LV size and is superior to SPECT MPI in patients with smaller LVs, highlighting the

258 d single photon emission computed tomography SPECT for the detection and evaluation of coronary arter

259 single photon emission computed tomography (SPECT) and X-ray computed tomography (CT) for investigat

260 single-photon emission computed tomography (SPECT) imaging at 1 and 3 hours.

261 single photon emission computed tomography (SPECT) imaging, but as a lipophilic cation its distribut

262 single-photon emission computed tomography (SPECT) imaging.

263 single photon emission computed tomography (SPECT) is feasible using cardiac cameras with solid-stat

264 single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) have shown a s

265 single-photon emission computed tomography (SPECT) predicts response to methylphenidate, a stimulant

266 single-photon emission computed tomography (SPECT), and positron emission tomography (PET) for ische

267 single-photon emission computed tomography (SPECT), comprise the imaging component of nuclear medici

268 single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), and luminescen

269 single-photon emission computed tomography (SPECT)/computed tomography (CT), autoradiography, and fl

270 ion computed tomography/computed tomography (SPECT/CT) and to estimate the accuracy of SC, PS and SPE

271 y single-photon emitted computed tomography (SPECT/CT) providing a convenient method for determining

272 t (LNI) underwent pelvic (99m)Tc-trofolastat SPECT/CT before radical prostatectomy with extended pelv

273 mainly a convolved version of the underlying SPECT reconstruction.

274 mainly a convolved version of the underlying SPECT reconstruction.

275 Scaling up SPECT did not show major changes in any region.

276 ged up to 4 times between days 0 and 7 using SPECT/CT.

277 tumor and normal tissues was measured using SPECT/CT imaging in vivo.

278 esponse after (177)Lu-DOTATATE therapy using SPECT imaging with (111)In-anti-gammaH2AX-TAT.

279 rom (129)Xe MRI (rho = 0.67; P < .001) and V-SPECT (rho = 0.59; P < .001).

280 rom (129)Xe MRI (rho = 0.67; P < .001) and V-SPECT (rho = 0.65; P < .001).

281 etween the FAN and (129)Xe MRI and FAN and V-SPECT were 0.16 +/- 0.08 and 0.28 +/- 0.14, respectively

282 om breath-hold time-series (129)Xe MRI and V-SPECT.

283 ared with that measured at (129)Xe MRI and V-SPECT.

284 anar method, -0.61 for L4-SPECT, -0.63 for V-SPECT, -0.63 for L-SPECT, and -0.57 for T-SPECT.

285 osol SPECT ventilation imaging (hereafter, V-SPECT) in participants with COPD.

286 esults: Using the planar method, L4-SPECT, V-SPECT, L-SPECT, and T-SPECT, the estimated median bone m

287 concentration in the L4 vertebra, whereas V-SPECT, L-SPECT, and T-SPECT used the median activity con

288 crimination of CAD by flurpiridaz PET versus SPECT in the overall population, in women, obese patient

289 ole-body planar scans, focused-field-of-view SPECT/CT scans, and whole-body (124)I-MIBG PET scans fou

290 erior) planar imaging, focused-field-of-view SPECT/CT, and whole-body (124)I-MIBG PET/CT (1.05 MBq/kg

291 olabeling with (99m)Tc, we performed in vivo SPECT imaging, biodistribution, and fluorescence imaging

292 taining orthotopic breast tumors for in vivo SPECT/MRI and biodistribution studies after injection wi

293 ients were discharged after imaging, whereas SPECT/CT patients left the department earlier, just afte

294 ndidate tracer for imaging of apoptosis with SPECT, as well as PET.

295 w to allow in vivo imaging of apoptosis with SPECT.

296 que for assessing myocardial blood flow with SPECT.

297 er analogs allowed tumor identification with SPECT and fluorescence imaging, (99m)Tc-EuK-(SO(3))Cy5-m

298 In this work, SPECT/CT-based voxel-based dosimetry of a 3D printed 2-c

299 In this work, SPECT/CT-based voxel-level dosimetry of a 3-dimensional

300 (99m)Tc-MAA SPECT/CT, and yttrium 90 ((90)Y) SPECT/CT or PET/CT was scored as optimal, suboptimal, or